Tesla shifts AI strategy, ending Dojo project and partnering with Samsung for next-gen self-driving chips amid challenges in electric vehicle sales and robotaxi rollout.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Waterslide malfunction on Royal Caribbean's Icon of the Seas injures passenger, prompting investigation.
Tesla shifts AI strategy, ending Dojo project and partnering with Samsung for next-gen self-driving chips amid challenges in electric vehicle sales and robotaxi rollout.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Waterslide malfunction on Royal Caribbean's Icon of the Seas injures passenger, prompting investigation.